Standard Treatments Regimens

Solid Tumour Standard Treatments

Type of Cancer
First Line
Second Line
Non-Small Cell Lung Cancer (NSCLC) Carboplatin / Taxol Alimta
Small Cell Lung Cancer (SCLC) Carboplatin / Etopophos Cyclophosphamide / Adriamycin / Vincristine
Melanoma DTIC / Fotemustine Cisplatin
Early Colorectal Cancer FOLFOX / Capecitabine
Metastatic Colorectal Cancer FOLFOX (modified 46hr infusion 5-FU) FOLFIRI
Early Prostate Cancer Docetaxel & Prednisone Mitozantrone
Hormone Refractory Metastatic Prostate Cancer Docetaxel & Prednisone Mitozantrone
Early Breast Cancer Multiple options
Metastatic Breast Cancer AC / Hormonal Therapy Multiple Options
Metastatic Transitional Cell Carcinoma
of the Bladder
Cisplatin / Gemcitabine
Mesothelioma Cisplatin / Alimta
Metastatic Renal Cell Carcinoma Sunitinib
Metastatic Hepatocellular Carcinoma Sorafenib
Metastatic Gastroesophageal Adenocarcinoma ECF
Metastatic Pancreatic Cancer Gemcitabine
Ovarian Cancer Carboplain / Paclitaxel Multiple Options
Endometrial Cancer Cisplatin / Adriamycin Provera
Head and Neck Squamous Cell Carcinoma Cisplatin / 5-FU Methotrexate

 

Haematological Standard Treatments

Type of Cancer
First Line
Second Line
Non-Hodgkin’s Lymphoma (NHL) R-CHOP
R-CVP
RICE
Hodgkin’s Lymphoma ABVD,
BEACOPP14
RICE
Chronic Lymphocyctic Leukaemia FC
FCR
Chlorambucil
FC
FCR
Small Lymphocytic Leukaemia FC
FCR
Chlorambucil
FC
FCR
Mulitple Myeloma CID
MP
Thalidomide / Dexamethasone
Idiopathic Thrombocytopaenic Purpura Prednisone Intragam